Chickasha, OK
Meet our Principal Investigator’s
Dr. Raymond Cornelison, MD
Principal Investigator
Raymond L. Cornelison, Jr., M.D., has extensive experience in dermatology, holding multiple academic and clinical positions at the University of Oklahoma Health Sciences Center from 1969 to 2011, including Professor and Herzog Chair. He has conducted numerous clinical trials as Principal Investigator, focusing on treatments for psoriasis, atopic dermatitis, and acne vulgaris. Dr. Cornelison is board certified in Dermatology and Dermatopathology and has held leadership roles in professional societies such as the American Academy of Dermatology and the Oklahoma State Dermatological Society.
Dr. Ahmad Musa, MD
Principal Investigator
Dr. Ahmad Musa is a Principal Investigator at Epic Medical Research, Oklahoma. He holds an MBBCH from Misr University for Science and Technology and completed residency training in General Surgery at NYU Long Island Hospital and University of Jordan Hospital. Dr. Musa is certified by the Educational Commission for Foreign Medical Graduates (ECFMG) and licensed in Oklahoma. He has extensive experience in clinical research, having led numerous Phase 2 and Phase 3 trials across a variety of medical conditions including COVID-19, NASH, and rheumatoid arthritis.
Dr. James Freed, MD
Principal Investigator
Dr. James Freed, a Board Certified Pediatrician and member of the American Academy of Pediatrics, leads Epic Medical Research in Oklahoma. He completed his residency and internship at Children’s Hospital in Oklahoma City and holds medical licensure in Oklahoma. With extensive experience as a Principal Investigator, Dr. Freed has conducted numerous Phase 2 and 3 clinical trials, focusing on COVID-19 and other infectious diseases, for renowned organizations like Moderna, Pfizer, Gilead Sciences, and AstraZeneca.
| Ability to scale based off individual protocol need | ACLS and BLS | Bilingual staff (English and Spanish) | -80º/-20ºC Freezers |
| Expedited startup, contract and budget, and enrollment capabilities | Multiple locations with unique patient populations | Lab Technicians | Refrigerators |
| Partnerships with various specialty physicians and medical imaging centers | Sites located within close proximity to major hospitals | Proprietary SOPs, processes and procedures | Continuous temperature monitoring devices |
| CLIA certified laboratory | Crash Carts | Quality Control Systems | Ambient/refrigerated centrifuges |
| Highly educated/experienced and trained staff | Access to multiple EMR and research databases | Quality Assurance Systems/Polysomnography capabilities | Limited access, temperature-controlled, document and drug storage |
| GCP certified/Shipping Dangerous Goods certified | Dedicated Clinical Research staff | Fully calibrated equipment and certificates | DEA drug compliance |
Our Facility
Study Areas
Cutaneous Lupus
Atopic dermatitis
Pneumococcal Disease
Norovirus
Cytomegalovirus Infection (CMV)
Covid-19 Treatment
Hidradenitis suppurativa
Sleep Apnea
NASH (Nonalcoholic Steatohepatitis)
Covid-19 Vaccine
Diabetes Type 2 and Obesity
Gastroesophageal Reflux Disease (GERD)
